Pharmaron Beijing Dividends and Buybacks
Dividend criteria checks 2/6
Pharmaron Beijing is a dividend paying company with a current yield of 0.75% that is well covered by earnings.
Key information
0.7%
Dividend yield
-0.04%
Buyback Yield
| Total Shareholder Yield | 0.7% |
| Future Dividend Yield | 1.0% |
| Dividend Growth | 27.5% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.200 |
| Payout ratio | 19% |
Recent dividend and buyback updates
Recent updates
At CN¥29.44, Is It Time To Put Pharmaron Beijing Co., Ltd. (SZSE:300759) On Your Watch List?
Nov 15
Pharmaron Beijing Co., Ltd. (SZSE:300759) Shares Fly 29% But Investors Aren't Buying For Growth
Sep 27Pharmaron Beijing Co., Ltd. (SZSE:300759) Shares Could Be 22% Below Their Intrinsic Value Estimate
Sep 20Pharmaron Beijing Co., Ltd.'s (SZSE:300759) Intrinsic Value Is Potentially 69% Above Its Share Price
May 12Pharmaron Beijing Co., Ltd.'s (SZSE:300759) 27% Share Price Surge Not Quite Adding Up
Mar 04Pharmaron Beijing (SZSE:300759) Seems To Use Debt Quite Sensibly
Feb 27Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, 300759 has been paying a dividend for less than 10 years.
Growing Dividend: 300759's dividend payments have increased, but the company has only paid a dividend for 6 years.
Dividend Yield vs Market
| Pharmaron Beijing Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (300759) | 0.7% |
| Market Bottom 25% (CN) | 0.5% |
| Market Top 25% (CN) | 2.1% |
| Industry Average (Life Sciences) | 1.2% |
| Analyst forecast (300759) (up to 3 years) | 1.0% |
Notable Dividend: 300759's dividend (0.75%) is higher than the bottom 25% of dividend payers in the CN market (0.53%).
High Dividend: 300759's dividend (0.75%) is low compared to the top 25% of dividend payers in the CN market (2.08%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (18.8%), 300759's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (95.9%), 300759's dividend payments are not well covered by cash flows.